BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Seattle Genetics and Astellas Initiate Phase 1b Trial of Enfortumab Vedotin in Combination with Immune Checkpoint Inhibitor Therapies in Locally Advanced or Metastatic Urothelial Cancer

  Enfortumab vedotin is an investigational antibody-drug conjugate (ADC) designed to deliver the cell-killing agent monomethyl auristatin E (MMAE) to the target Nectin-4.

  November 8, 2017

   · 

  8 min read
• Lone Star Bio

  Asuragen to Present at Upcoming 2017 Association for Molecular Pathology (AMP) Annual Meeting

  Asuragen will host a corporate workshop and present three posters at the 2017 Association for Molecular Pathology (AMP) Conference November 15-18 in Salt Lake City.

  November 8, 2017

   · 

  4 min read
• Drug Development

  Synlogic Reports Positive Top-Line Phase 1 Data Demonstrating Safety and Tolerability and Proof of Mechanism in Healthy Volunteers for SYNB1020, a Synthetic BioticTM Medicine for the Treatment of Hyperammonemia

  The trial successfully met the primary objectives demonstrating safety and tolerability in healthy volunteers and identifying the maximum tolerated dose.

  November 8, 2017

   · 

  9 min read
• Business

  IsoRay Announces First Quarter Fiscal 2018 Earnings Conference Call

  IsoRay today announced that it will host a teleconference to discuss first quarter fiscal 2018 financial results on Tuesday, November 14, 2017, at 4:30 p.m. Eastern Time.

  November 8, 2017

   · 

  1 min read
• Photometrics Sets a New Standard in Scientific Imaging With Prime BSI CMOS Camera

  Prime BSI is a versatile camera for live cell techniques, including Total Internal Reflection Fluorescence, Ratiometric Imaging and Light Sheet microscopy.

  November 8, 2017

   · 

  3 min read
• Business

  CellSight Technologies Announces Strategic Collaboration With Boehringer Ingelheim to Develop a New Technology for Monitoring Anti-Tumor T-Cell Activation

  The focus of the trial is to determine if early PET scans, at 6-12 weeks after the initial anti-PD1 inhibitor therapy dose, with the VisAcT tracer are predictive of response to immunotherapy.

  November 8, 2017

   · 

  2 min read
• Biotech Beach

  Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2017 Earnings Release and Conference Call

  The Company will host a conference call on Tuesday, November 14, 2017, at 4:15 p.m. Eastern Time.

  November 8, 2017

   · 

  1 min read
• Business

  MEI Pharma Reports First Quarter Fiscal Year 2018 Results

  MEI Pharma today reported results for its first quarter ended September 30, 2017.

  November 8, 2017

   · 

  10 min read
• Business

  TECHLAB Receives USDA Establishment License and Product License for GIARDIA VET CHEK™

  The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the first USDA licensed Giardia microwell ELISA available in the US veterinary market.

  November 8, 2017

   · 

  1 min read
• Drug Development

  BioPharmX Receives Concurrence From FDA on Phase III Acne Study Plans

  The company has incorporated feedback from the FDA on key elements of its phase III acne program.

  November 8, 2017

   · 

  5 min read